JD Health International Inc. (FRA:8ZN1)
Germany · Delayed Price · Currency is EUR 6.60
0.00 (0.00%)
At close: Jan 30, 2026
JD Health International Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 4,721 | 4,162 | 2,142 | 380.11 | -1,074 | -17,234 |
Depreciation & Amortization | 231.82 | 214.7 | 227.46 | 140.68 | 63.17 | 27.22 |
Loss (Gain) From Sale of Investments | -1,345 | -1,345 | -93.51 | 106.17 | -94.21 | -60.5 |
Loss (Gain) on Equity Investments | 85.53 | 85.53 | 70.76 | 96.76 | 94.17 | 77.02 |
Stock-Based Compensation | 1,130 | 1,130 | 1,848 | 2,104 | 2,580 | 380.3 |
Provision & Write-off of Bad Debts | 315.85 | 315.85 | 69.86 | 98.2 | 38.35 | 0.12 |
Other Operating Activities | 2,684 | -754.53 | 126.21 | 129.82 | -204.17 | 17,594 |
Change in Accounts Receivable | -212.71 | -212.71 | 537.14 | -685.08 | -331.4 | -47.66 |
Change in Inventory | -523.37 | -523.37 | 791.61 | -3,151 | -1,286 | -522.21 |
Change in Accounts Payable | 759.93 | 759.93 | -865.58 | 5,041 | 2,585 | 2,448 |
Change in Unearned Revenue | 132.31 | 132.31 | -969.35 | 979.54 | 215.95 | 91.78 |
Change in Other Net Operating Assets | 368.56 | 368.56 | 720.57 | 665.08 | 843.36 | 945.76 |
Operating Cash Flow | 8,347 | 4,332 | 4,605 | 5,905 | 3,431 | 3,699 |
Operating Cash Flow Growth | 29.07% | -5.92% | -22.02% | 72.13% | -7.26% | 803.48% |
Capital Expenditures | -61.55 | -38.6 | -61.18 | -40.16 | -502.21 | -15.7 |
Cash Acquisitions | - | - | - | - | - | -3.5 |
Sale (Purchase) of Intangibles | - | - | - | -2,233 | -7.88 | -21.91 |
Investment in Securities | 8,127 | 3,210 | -7,971 | -1,957 | -17,247 | -7,559 |
Other Investing Activities | -102.07 | -25.04 | 9.48 | -5.41 | 5.18 | -242.91 |
Investing Cash Flow | 7,963 | 3,146 | -8,023 | -4,236 | -17,752 | -7,843 |
Short-Term Debt Repaid | - | - | - | - | - | -216.71 |
Long-Term Debt Repaid | - | -37.41 | -33.83 | -47.56 | -32.33 | -26.21 |
Total Debt Repaid | -45.77 | -37.41 | -33.83 | -47.56 | -32.33 | -242.92 |
Net Debt Issued (Repaid) | -45.77 | -37.41 | -33.83 | -47.56 | -32.33 | -242.92 |
Issuance of Common Stock | - | - | - | - | - | 25,791 |
Repurchase of Common Stock | - | - | -69.1 | -869.04 | -56.3 | - |
Other Financing Activities | -8.34 | -8.19 | -14.27 | -8.85 | -75.02 | -2.44 |
Financing Cash Flow | -54.11 | -45.61 | -117.2 | -925.45 | -163.65 | 32,029 |
Foreign Exchange Rate Adjustments | 78.51 | 158.64 | -145.38 | 721.27 | -533.41 | -580.05 |
Net Cash Flow | 16,334 | 7,592 | -3,681 | 1,465 | -15,018 | 27,306 |
Free Cash Flow | 8,285 | 4,294 | 4,544 | 5,865 | 2,929 | 3,684 |
Free Cash Flow Growth | 28.82% | -5.50% | -22.53% | 100.27% | -20.50% | 811.18% |
Free Cash Flow Margin | 12.73% | 7.38% | 8.49% | 12.55% | 9.54% | 19.01% |
Free Cash Flow Per Share | 2.61 | 1.36 | 1.44 | 1.86 | 0.95 | 1.67 |
Cash Interest Paid | 8.34 | 8.19 | 9.49 | 8.85 | 4.91 | 2.44 |
Cash Income Tax Paid | 496.3 | 634.59 | 496.91 | 153.01 | 249.98 | 174.86 |
Levered Free Cash Flow | 5,778 | 2,353 | 2,753 | 3,164 | 3,222 | 3,563 |
Unlevered Free Cash Flow | 5,783 | 2,358 | 2,759 | 3,170 | 3,225 | 3,565 |
Change in Working Capital | 524.74 | 524.74 | 214.38 | 2,849 | 2,027 | 2,916 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.